{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T05:17:48Z","timestamp":1736227068336,"version":"3.32.0"},"reference-count":45,"publisher":"Informa UK Limited","issue":"13","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2023,11,10]]},"DOI":"10.1080\/10428194.2023.2252123","type":"journal-article","created":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T03:49:45Z","timestamp":1694836185000},"page":"2156-2164","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Temporal trend in survival for chronic myelomonocytic leukemia in the US: a population-based study"],"prefix":"10.1080","volume":"64","author":[{"given":"Arnaud","family":"Lesegretain","sequence":"first","affiliation":[{"name":"Harvard Medical School, Boston, MA, USA"},{"name":"Daiichi Sankyo, Basking Ridge, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Brunner","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aziz","family":"Benzohra","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo, Basking Ridge, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir T.","family":"Fathi","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-017-2243-z"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25684"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-019-1526-1"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2017.0007"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-736421"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.801524"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071610"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26667"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21792"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.04.117"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70003-8"},{"key":"e_1_3_3_14_1","unstructured":"Azacitdine FDA Package Insert. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/050974s034lbl.pdf"},{"key":"e_1_3_3_15_1","unstructured":"Decitabine FDA Package Insert. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/021790s021lbl.pdf"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-05-352039"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2007.08.004"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.719617"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2012.04.024"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.01.004"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25759"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.730615"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.85"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2016.1138295"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.186"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2014.01.006"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30814"},{"key":"e_1_3_3_28_1","unstructured":"Surveillance Epidemiology and End Results (SEER) Program. Available from: www.seer.cancer.gov"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000749"},{"key":"e_1_3_3_30_1","unstructured":"Surveillance Epidemiology and End Results (SEER) Program. SEER*Stat Database: Incidence \u2013 SEER Research Plus Data 17 Registries Nov 2021 Sub (2000\u20132019) \u2013 Linked To County Attributes \u2013 Time Dependent (1990\u20132019) Income\/Rurality 1969\u20132020 Counties National Cancer Institute DCCPS Surveillance Research Program released April 2022 based on the November 2021 submission [cited 2022 Nov 21]. Available from: www.seer.cancer.gov\/seerstat"},{"key":"e_1_3_3_31_1","unstructured":"Surveillance Research Program. National Cancer Institute SEER*Stat software \u2013version 8.4.0.1 [cited 2022 Nov 21]. Available from: www.seer.cancer.gov\/seerstat"},{"key":"e_1_3_3_32_1","first-page":"101","article-title":"The relative survival rate: a statistical methodology","volume":"6","author":"Ederer F","year":"1961","unstructured":"Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr. 1961;6:101\u2013121.","journal-title":"Natl Cancer Inst Monogr"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19951115)76:10<1687::AID-CNCR2820761002>3.0.CO;2-I"},{"key":"e_1_3_3_34_1","unstructured":"Ederer F Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological note no. 10. Bethesda MD: End Results Evaluation Section National Cancer Institute; 1959."},{"key":"e_1_3_3_35_1","unstructured":"Products \u2013 Life Tables \u2013 Homepage ( cdc.gov)."},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/1536867X1501500112"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-778225"},{"key":"e_1_3_3_38_1","unstructured":"American Cancer Society Cancer Facts & Figures for African Americans 2019\u20132021. 2019. [cited 2022 Nov 21]. Available from: https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/cancer-facts-and-figures-for-african-americans\/cancer-facts-and-figures-for-african-americans-2019-2021.pdf"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2005.032813"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1579"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018019125"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.063602"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.06.012"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0b013e3181dea934"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2022.2032034"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2022.107006"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2023.2252123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T11:46:02Z","timestamp":1736163962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2023.2252123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":45,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2023,11,10]]}},"alternative-id":["10.1080\/10428194.2023.2252123"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2023.2252123","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"type":"print","value":"1042-8194"},{"type":"electronic","value":"1029-2403"}],"subject":[],"published":{"date-parts":[[2023,9,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-03-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}